Azenta, Inc. - Common Stock (AZTA)

19.22
+0.65 (3.50%)
NASDAQ · Last Trade: May 9th, 7:14 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
AZENTA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
The law firm of Kirby McInerney LLP is investigating potential claims against Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ:AZTA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
By Kirby McInerney LLP · Via Business Wire · May 8, 2026
5 medical stocks growing earnings by triple digits
There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning
Via MarketBeat · February 6, 2024
16 Top Robotics Companies to Get to Know in 2023
What are the top robotics companies in the USA, as robotics continues to grow? Learn more about the best companies today with MarketBeat.
Via MarketBeat · September 11, 2023
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19, 2023. Dr. Nova succeeds Brian Birk, who has served as Chair of the Board of Directors at Exagen since 2018, and who will remain a member of the Board.  
By Exagen Inc. · Via GlobeNewswire · January 23, 2023